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Abstract
Objective: Abdominal aortic aneurysm (AAA) affects up to 9% of adults, 
and the incidence of asymptomatic and ruptured AAA currently accounts for 
1–2% of male deaths. A number of studies have applied classical proteomics 
methodology to identify plasma biomarkers of AAA. 
The use of a systems biology protein-protein interaction network analysis on 
proteomics results can reveal novel mechanisms. 
Methods: We performed a bioinformatics analysis on a compiled set of 
proteins previously identified in multiple proteomics studies. Results from a total 
of nine papers were identified and included in the analysis. The 64 proteins 
related to AAA were first analyzed by over-representation analysis (ORA) using 
Webgestalt. Afterwards, the same input list was submitted to BioProfiling. This 
portal used statistical methodology for the network based interpretation of the 
protein list (Rspider, PPIspider). The networks obtained by both Reactome and 
PPI analysis were further analyzed by ORA using the JEPETTO application in 
the Cytoscape environment. 
Results: This analysis revealed a strong over-representation for proteins 
related not only to blood clotting but also to cellular mediated response, such as 
cell adhesion and cytokine activation of platelets and white blood cells. 
Conclusions: We used a network strategy to generate statistically valid 
novel hypotheses about biological mechanisms related to AAA, which may be 
useful in providing new insights into the understanding of the pathogenesis of 
AAA.
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approach, our team has confirmed several plasma biomarkers that 
others have previously identified as being associated with AAA 
[7-14]. New approaches to quantitatively identify low-abundance 
proteins (such as cytokines) and their functional analysis into specific 
protein networks are of crucial importance in the post-genomic era 
[15-17]. A classical proteomics approach has been used to identify 
in AAA subjects four serum proteins that show altered expression 
profiles specifically linked to AAA pathology [18,19]. Proteome 
analysis has been generally limited in complex samples such as serum 
and plasma that have a dramatically wide dynamic range of protein 
abundance. The use of pre-fractionated plasma samples revealed that 
patients with small AAA showed an increased level of the enzyme 
glycosyl phosphatidyl inositol-specific phospholipase D compared to 
controls without aneurysm [20]. However, smaller proteins may be 
part of larger protein complexes and hence the removal of proteins 
involved in complexes with high-abundance proteins such as albumin 
may inhibit the search for disease biomarkers [7]. In recent years, 
bioinformatics approaches have been applied to provide systems 
biology interpretations of proteomic data [21]. The focus of the present 
study was the application of bioinformatics to analyze all the proteins 
lists obtained by proteomics experiments performed on human AAA 
serum or plasma samples. A common approach to the visualization 
and examination of “omics” data involves the generation of a network 
of all the individual components of a given setof experiments [22,23]. 
Introduction 
Abdominal aortic aneurysm (AAA) affects up to 9% of adults 
older than 65 years of age [1]. The mortality rate for patients with 
ruptured AAA approaches 90%, with 40–50% of deaths occurring 
before the patient reaches the hospital. Asymptomatic AAA is easily 
detectable with abdominal ultrasound, and screening programs are 
now considered a reasonable practice option since surgical repair 
is restricted to AAA >5.5 cm at centers with acceptable operative 
mortality [2-6]. Identifying markers other than AAA size that 
would predict a risk of rupture is the focus of current investigation. 
For AAA, one significant limitation relates to the fact that many 
biomarkers are not disease specific; indeed most of them are also 
markers for atherosclerosis [7]. Serum Elastin Peptide holds promise 
to be an improved biomarker to predict AAA expansion and rupture 
[8-10] because it positively correlates between its plasma level and 
the AAA growth rate [10]. The extent of aortic dilation and vessel 
tortuosity is associated with blood levels of several fibrinolytic 
factors, including D-dimer, fibrinogen/fibrin degradation products, 
and plasmin inhibitor-plasmin complexes [11]. Specifically, there is a 
positive correlation between AAA size and fibrinogen concentration 
in the plasma [12]. For AAA many of the identified differences in 
the serum proteome often represented proteins highly abundant in 
serum rather than true candidate biomarkers [13]. Using a proteomic 
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We used a network strategy to generate statistically valid hypotheses 
about biological mechanisms related to AAA and to provide new 
insight into the understanding of pathogenesis of such a complex 
disease [24]. To proceed we carried out a detailed bioinformatics 
analysis (using open source software for analyses/interpretation of 
biological data and visualization of complex networks obtained) on 
proteins identified in previous proteomics. Such an approach is being 
used with increased frequency, and such applications increase our 
understanding of complex human diseases including cardiovascular 
diseases [25].
Methods 
Literature search to obtain the protein input list 
Publications with the medical subject heading “abdominal 
aortic aneurysms” and keywords “proteomics” and “plasma” and 
“progression” or “growth” or “expansion rate” or “rupture” were 
searched in the MEDLINE/PubMed and EMBASE databases. The 
search was restricted until May 2013. Only human studies that 
reported aneurysm size, expansion rates and plasma markers were 
selected. 
Bioinformatics analysis 
We performed over-representation analysis (ORA) of the 
protein list obtained by the literature search (the input list) using the 
Webgestalt online tool (http://bioinfo.vanderbilt.edu/webgestalt/) 
against Gene Ontology (GO), Kyoto Encyclopedia of Genes and 
Genomes (KEGG), WikiPathway and Pathway Commons databases 
[26]. The analysis of functional genomics data often involves the 
assessment of potential functional associations between a protein set 
of interest. To identify these putative associations several enrichment 
analysis tools have been developed including over-representation 
analysis (ORA) techniques. This method assess the statistical over-
representation of a user-defined, pre-selected gene/protein list of 
interest in a reference list of known gene/protein sets using a statistical 
test, e.g. the one-sided Fisher’s exact test or the hypergeometric 
distribution. 
Figure 1: Linear regression analysis and Pearson correlation of Xd scores 
as obtained with the JEPETTO application vs the corrected p-value of the 
Fisher exact test. Xd values greater than the intercept of the linear model are 
considered as significant. 
Figure 2: Gene Ontology over-representation analysis of the input list 
performed by Webgestalt significantly over-represented categories are 
highlighted in red. Panel A: GO Biological Process (BP). Panel B: GO 
Molecular Function (MF). Panel C: Cellular Component (CC).
Austin J Proteomics Bioinform & Genomics 1(1): id1006 (2014)  - Page - 03
Alessandra Modesti and Pietro A. Modesti Austin Publishing Group
Submit your Manuscript | www.austinpublishinggroup.com
Uniprot accession 
number Gene Symbol Protein name Reference 
O00175 CCL24 chemokine (C-C motif) ligand 24 [17] 
O43927 CXCL13 chemokine (C-X-C motif) ligand 13 [17] 
P00450 CP ceruloplasmin (ferroxidase) [14,18] 
P00734 F2 coagulation factor II (thrombin) [14,20] 
P00738 HP haptoglobin [7,14,18] 
P00748 F12 coagulation factor XII (Hageman factor) [16] 
P00751 CFB complement factor B [7,14] 
P01009 SERPINA1 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 [7,14,16,20] 
P01011 SERPINA3 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 [14] 
P01023 A2M alpha-2-macroglobulin [7,14] 
P01024 C3 complement component 3 [16] 
P01042 KNG1 kininogen 1 [7] 
P01579 IFNG interferon, gamma [20] 
P01834 IGKC immunoglobulin kappa constant [16] 
P01857 IGHG1 immunoglobulin heavy constant gamma 1 (G1m marker) [19] 
P01859 IGHG2 immunoglobulin heavy constant gamma 2 (G2m marker) [19] 
P01871 IGHM immunoglobulin heavy constant mu [19] 
P02647 APOA1 apolipoprotein A-I [7,14,18,20] 
P02655 APOC2 apolipoprotein C-II [13] 
P02671 FGA fibrinogen alpha chain [7,14] 
P02675 FGB fibrinogen beta chain [14] 
P02679 FGG fibrinogen gamma chain [7,14,18] 
P02741 CRP C-reactive protein, pentraxin-related [20] 
P02743 APCS amyloid P component, serum [18] 
P02750 LRG1 leucine-rich alpha-2-glycoprotein 1 [7,14] 
P02753 RBP4 retinol binding protein 4, plasma [14] 
P02760 AMBP alpha-1-microglobulin/bikunin precursor [15] 
P02765 AHSG alpha-2-HS-glycoprotein [7,14] 
P02768 ALB albumin [13,14,16] 
P02774 GC group-specific component (vitamin D binding protein) [7,18] 
P02775 PPBP pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) [15] 
P02787 TF transferrin [7,14,18] 
P02790 HPX hemopexin [7,18] 
P05546 SERPIND1 serpin peptidase inhibitor, clade D (heparin cofactor), member 1 [15] 
P06396 GSN gelsolin [15,19] 
P06727 APOA4 apolipoprotein A-IV [14] 
P07737 PFN1 profilin 1 [15] 
P08185 SERPINA6 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 [15] 
P08294 SOD3 superoxide dismutase 3, extracellular [15] 
P08567 PLEK pleckstrin [15] 
P08697 SERPINF2 
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), 
member 2 [15,20] 
P08833 IGFBP1 insulin-like growth factor binding protein 1 [17] 
P09237 MMP7 matrix metallopeptidase 7 (matrilysin, uterine) [20] 
P0C0L5 LOC100293534 complement C4-B-like [18] 
P10909 CLU clusterin [7,14] 
P12814 ACTN1 actinin, alpha 1 [15] 
P14151 SELL selectin L [17] 
P15169 CPN1 carboxypeptidase N, polypeptide 1 [15] 
P15502 ELN elastin [20] 
P18065 IGFBP2 insulin-like growth factor binding protein 2, 36kDa [17] 
P18206 VCL vinculin [15] 
P19320 VCAM1 vascular cell adhesion molecule 1 [17] 
P21333 FLNA filamin A, alpha [15] 
P29622 SERPINA4 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 [15] 
Table 1: The input list.
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Afterwards the web portal BioProfiling.de (http://www.
bioprofiling.de/) was used to build enriched networks. This portal 
covered most of the available information regarding signaling and 
metabolic pathways (database: Reactome) and physical protein 
interactions (database: IntAct) [27]. Accordingly, the input list was 
analyzed by Rspider [28] and PPI spider [29,30]. Both tools employed 
advanced enrichment or network-based statistical frameworks. The 
p-value provided was computed by the Monte Carlo simulation 
(http://www.bioprofiling.de/statistical_frameworks.html) and 
referred to the probability of obtaining a model of the same quality 
for a random gene list of the same size [31]. The significant networks, 
using a cut-off of p < 0.01, were further considered for proteomics 
data interpretation and discussion. The enriched network was 
exported as an .xgmml file and visualized and modified by Cytoscape 
3.1.0 (http://www.cytoscape.org/) [32]. Moreover, the Cytoscape 
Jepetto (Java Enrichment of Pathways Extended to Topology) 
application was employed to perform ORA of the enriched networks 
[33] (http://apps.cytoscape.org/apps/jepetto). For the enrichment 
analysis by JEPETTO, EnrichNet server is used. EnrichNet maps 
the input gene set onto a molecular interaction network and, using 
a random walk, scores distances between the genes and pathways/
processes in a reference database. This network-based association 
score (XD-score) is relative to the average distance to all pathways 
and represents a deviation (positive or negative) from the average 
distance. Significantly over-represented pathways were selected if 
theirXd score was greater than that calculated as the intercept of the 
linear regression of Xd scores vs the Fisher’s exact test p-value after 
Benjamini-Hochberg correction (q-value; Figure 1) [34]. 
Results and Discussion 
Literature analysis of proteomics studies of plasma AAA 
associated markers. Nine published proteomics studies were used 
to generate an input protein set of 64 seed proteins (the input list). 
The proteins included in the input list were differentially expressed 
in plasma from AAA patients with respect to controls. The 64 seed 
proteins are reported in Table 1.
Over-representation analysis of the input list
The input list was uploaded to the Webgestalt portal and ORA 
was performed. Figure 2 shows the significantly over-represented 
GO Biological Processes (BP, Panel A), Molecular Functions (MF, 
Panel B) and Cellular Components (CC, Panel C) in the input protein 
set (for details, see Supplementary Table 1). As expected for this 
pathology, we found enriched Gene Ontology Biological Process 
(GO BP) terms involved in response mechanisms to generic stress 
conditions, including response to stress (GO:0006950 - 47 genes); 
and inflammatory response (GO:0006954 – 20 genes). Other BP 
terms appear to be more closely related to the pathological condition 
being investigated, namely hemostasis (GO: 0007599 – 25 genes); 
blood coagulation (GO: 0007596 – 25 genes); and the related protein 
activation cascade (GO: 0072376 – 8 genes). Of note, some of the BP 
terms corresponded to processes involved in transport and secretion, 
P39905 GDNF glial cell derived neurotrophic factor [17] 
P61626 LYZ lysozyme [15] 
P68871 HBB hemoglobin, beta [7,13] 
P78556 CCL20 chemokine (C-C motif) ligand 20 [17] 
P80108 GPLD1 glycosylphosphatidylinositol specific phospholipase D1 [19] 
Q01518 CAP1 CAP, adenylate cyclase-associated protein 1 (yeast) [15] 
Q14624 ITIH4 inter-alpha-trypsin inhibitor heavy chain family, member 4 [19] 
Q15848 ADIPOQ adiponectin, C1Q and collagen domain containing [15,17] 
Q96IY4 CPB2 carboxypeptidase B2 (plasma) [15] 
Q9Y490 TLN1 talin 1 [15] 
PathwayName #Gene EntrezGene Statistics 
Complement and coagulation cascades 14 
P0C0L5 P01024 P01009 Q96IY4 
P05546 P01023 P01042 P02675 
P02679 P00751 P02671 Q8IZZ5 
P00748 
C=69;O=14;E=0.10;R=136.73;rawP=7.9
1e-27;adjP=1.66e-25 
African trypanosomiasis 4 P01579 P68871 P19320 P02647 C=35;O=4;E=0.05;R=77.01;rawP=2.2
3e-07;adjP=2.34e-06 
Staphylococcus aureus infection 4 P0C0L5 P01024 P02679 P00751 C=55;O=4;E=0.08;R=49.01;rawP=1.4
2e-06;adjP=9.94e-06 
Regulation of actin cytoskeleton 5 
P06396 P12814 P00734 P18206 
P07737 
C=213;O=5;E=0.32;R=15.82;rawP=1.6
9e-05;adjP=8.87e-05 
Systemic lupus erythematosus 4 P0C0L4 P01579 P01024 P12814 C=136;O=4;E=0.20;R=19.82;rawP=5.1
9e-05;adjP=0.0002 
Cytokine-cytokine receptor interaction 5 P01579 O00175 O43927 P78556 
P02775 
C=265;O=5;E=0.39;R=12.71;rawP=4.7
8e-05;adjP=0.0002 
Malaria 3 P01579 P68871 P19320 C=51;O=3;E=0.08;R=39.64;rawP=6.1
7e-05;adjP=0.0002 
Focal adhesion 4 P12814 P21333 P18206 Q9Y490 C=200;O=4;E=0.30;R=13.48;rawP=0.00
02;adjP=0.0005 
Chemokine signaling pathway 4 O00175 O43927 P78556 P02775 C=189;O=4;E=0.28;R=14.26;rawP=0.00
02;adjP=0.0005 
Amoebiasis 3 P01579 P12814 P18206 C=106;O=3;E=0.16;R=19.07;rawP=0.00
05;adjP=0.0010 
Table 2: Over-representation of KEGG pathways in the input dataset. p < 0.001 after Benjamini-Hochberg correction.
The statistics column lists: C: the number of reference genes in the category; O: the number of genes in the gene set and also in the category; E: the expected number 
in the category; R: ratio of enrichment; rawP: p value from the Fisher exact test; adjP: p value adjusted for multiple testing.
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role of cell-celland cell-ECM adhesion in the composition of the 
investigated signature. The set was then analyzed with respect to: 
KEGG (Table 2), Pathway Commons (Table 3) and Wiki Pathways 
(Table 4) databases. A significant over-representation of pathways 
related to blood coagulation and thrombin/plasmin cascades was 
found (14 genes), as expected. Additionally, evidence for a remarkable 
involvement of cell-mediated responses came to the light. Indeed, 
GO ORA suggested the role of soluble platelet activation markers as 
detectable in plasma. KEGG pathways indicated that a few proteins 
in the list were linked to focal adhesion (4 genes), cytokine-cytokine 
receptor interaction (5 genes) and chemokine signaling (4 genes). 
Results from the PathwayCommons ORA also supported the link of 
the proteins set with either cell-cell or cell-ECM adhesion processes 
(integrin family cell surface interaction - 21 genes, alpha9 beta1 
integrin signaling events - 19 gens, proteoglycan syndecan-mediated 
signaling events - 21 genes), in addition to pathways associated with 
blood coagulation and fibrinolysis (hemostasis - 18 genes; thrombin/
protease-activated receptor (PAR) pathway and PAR1-8 mediated 
thrombin signaling events - 19 genes for each pathway). In addition, 
WikiPathways ORA indicated a possible connection between the 
input list and reactive oxygen species scavenging (selenium pathway 
- 8 genes) and biosynthesis. As a whole, the ORA performed on the 
input list identified several elements of the protein signature not 
such as secretion by cell (GO: 0032940 – 24 genes); exocytosis (GO: 
0006887 – 19 genes); and platelet degranulation (GO: 0002576 – 19 
genes). As expected, the molecular functions related to coagulation 
proteases, including regulatory factors, were significantly enriched 
in the input list. Molecular function terms associated with receptor 
binding were over-represented in the list. The enriched GO MF 
terms contain ontologies involved in binding, including cell surface 
binding (GO: 0043498 – 7 genes); protein binding (GO: 0005515 - 47 
genes); and receptor binding (GO: 0005102 – 19 genes). There were 
also enriched GO MF terms involved in enzyme regulator activity, 
including enzyme inhibitor (GO: 0004857 - 13 genes); peptidase 
regulator (GO: 0061134 - 12 genes); peptidase inhibitor (GO:0030414- 
13 genes); endopeptidase regulator (GO:0061135-12 genes) and 
endopeptidase inhibitor (GO:0004866 - 12 genes). The enriched GO 
cellular components terms pointed out two major over-represented 
classes. The first were associated with the secretory pathway, which 
would be expected for platelet activation and included platelet alpha 
granule lumen (GO: 0031093 - 11 genes); and platelet alpha granule 
(GO: 0031091 – 11 genes). The other class was those components on 
the cell surface or in the extracellular region and included extracellular 
space (GO: 0005615 – 41 genes); extracellular region (GO: 0005576 
– 54 genes); extracellular region part (GO:0044421 – 42 genes); and 
extracellular matrix (GO:0031012 – 10 genes), suggesting a possible 
PathwayName #Gene EntrezGene Statistics 
Hemostasis 18 
P00734 Q9Y490 P01023 P14151 
P01042 P02679 P00748 P21333 
P02787 P68871 P08567 Q01518 
P07737 P02675 P02671 P08697 
P02647 P18206 
C=376;O=18;E=0.56;R=32.26;rawP=1.
41e-22;adjP=1.71e-20 
Platelet degranulation 8 Q9Y490 P21333 P02787 P08567 
Q01518 P07737 P02647 P18206 
C=29;O=8;E=0.04;R=185.89;rawP=6.2
5e-17;adjP=3.78e-15 
Proteoglycan syndecan-mediated 
signaling events 21 
P01579 P00734 P00450 Q9Y490 
P08833 P01023 P25090 P02679 
P12814 P21333 P02787 P80108 
P02765 P06396 P09237 P39905 
P02675 P02671 P10909 P18206 
P02741 
C=1345;O=21;E=2.00;R=10.52;rawP=2
.32e-16;adjP=9.36e-15 
Integrin family cell surface interactions 21 
P01024 P01579 P00450 Q9Y490 
P08833 P01023 P25090 
P02679P12814 P02787 P80108 
P02765 P06396 P09237 P39905 
P19320 P02675 P02671 P10909 
P18206 P02741 
C=1378;O=21;E=2.04;R=10.27;rawP=3
.76e-16;adjP=1.14e-14 
Response to elevated platelet cytosolic 
Ca2+ 8 
Q9Y490 P21333 P02787 P08567 
Q01518 P07737P02647P18206 
C=40;O=8;E=0.06;R=134.77;rawP=1.1
1e-15;adjP=2.69e-14 
Alpha9 beta1 integrin signaling events 19 
P01579 P00450 Q9Y490 P08833 
P01023 P02679 P12814 P02787 
P80108 P02765 P06396 P09237 
P19320 P39905 P02675 P02671 
P10909 P18206 P02741 
C=1305;O=19;E=1.94;R=9.81;rawP=2.
89e-14;adjP=4.37e-13 
PAR1-mediated thrombin signaling 
events 19 
P01579 P00734 P00450 Q9Y490 
P08833 P01023 P02679 P12814 
P02787 P80108 P02765 P06396 
P09237 P39905 P02675 P02671 
P10909 P18206 P02741 
C=1299;O=19;E=1.93;R=9.86;rawP=2.
66e-14;adjP=4.37e-13 
Thrombin/protease-activated receptor 
(PAR) pathway 
19 
P01579 P00734 P00450 Q9Y490 
P08833 P01023 P02679 P12814 
P02787 P80108 P02765 P06396 
P09237 P39905 P02675 P02671 
P10909 P18206 P02741 
C=1300;O=19;E=1.93;R=9.85;rawP=2.
69e-14;adjP=4.37e-13 
Formation of Fibrin Clot (Clotting 
Cascade) 7 
P00734 P01023 P01042 P02679 
P00748 P02675 P02671 
C=33;O=7;E=0.05;R=142.94;rawP=4.6
8e-14;adjP=5.66e-13 
Table 3: Over - Representation of  pathway commons pathways in the input dataset. p < 0.001 after Benjamini-Hochberg correction.
The statistics column lists: C: the number of reference genes in the category; O: the number of genes in the gene set and also in the category; E: the expected number 
in the category; R: ratio of enrichment; rawP: p value from the Fisher exact test; adjP: p value adjusted for multiple testing.
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directly related to wound healing and/or coagulation. Among those, 
the presence of soluble platelet activation markers and of proteins 
involved in cellular processes at the cell surface could represent an 
interesting hint to look for novel prognostic AAA markers. To further 
reinforce this finding, we performed network enrichment analysis. 
Network enrichment 
In order to discriminate the number of proteins that could 
be associated to disease, the protein set was enriched in terms of a 
PathwayName #Gene EntrezGene Statistics 
Complement and Coagulation 
Cascades 10 
P01024 P00734 P01009 P05546 
Q96IY4 P01023 P01042 P02675 
P00748 P08697 
C=51;O=10;E=0.08;R=132.13;rawP=3.
01e-19;adjP=4.52e-18 
Blood Clotting Cascade 6 P00734 P02679 P02675 P00748 
P02671 P08697 
C=26;O=6;E=0.04;R=155.51;rawP=1.8
9e-12;adjP=1.42e-11 
Selenium Pathway 8 P68871 P01579 P00734 P02768 
P01011 P02647 P02741 P08294 
C=108;O=8;E=0.16;R=49.92;rawP=4.6
8e-12;adjP=2.34e-11 
Regulation of Actin Cytoskeleton 5 
P00734 P06396 P07737 P12814 
P18206 
C=157;O=5;E=0.23;R=21.46;rawP=3.8
5e-06;adjP=1.44e-05 
Vitamin B12 Metabolism 3 P68871 P08294 P02647 
C=24;O=3;E=0.04;R=84.23;rawP=6.1
7e-06;adjP=1.85e-05 
Folate Metabolism 3 P68871 P08294 P02647 C=29;O=3;E=0.04;R=69.71;rawP=1.1
1e-05;adjP=2.64e-05 
Statin Pathway 3 P02655 P06727 P02647 C=30;O=3;E=0.04;R=67.39;rawP=1.2
3e-05;adjP=2.64e-05 
Table 4: Over-Representation of WikiPathways entries in the input dataset. p < 0.001 after Benjamini-Hochberg correction.
The statistics column lists: C: the number of reference genes in the category; O: the number of genes in the gene set and also in the category; E: the expected number 
in the category; R: ratio of enrichment; rawP: p value from the Fisher exact test; adjP: p value adjusted for multiple testing.
network-based statistical framework. As a first approach, a pathway-
based network was built by allowing the insertion of no more than 1 
or 2 intermediate nodes using the Reactome database as a reference 
(Figure 3). In both cases, highly interconnected networks were 
obtained, with 12 nodes (Figure 3, Panel A) and 18 nodes (Figure 3, 
Panel B) overlapping with the input list, respectively. Furthermore, 
a physical-interaction-based network was built by limiting the 
insertion of enriched nodes to one or two using the Int Act database 
Figure 3: Enriched networks obtained with Rspider. Panel A: A maximum 
of one intermediate node was allowed to be added. Panel B: A maximum of 
two intermediate nodes was allowed to be added. Network visualization was 
obtained using Cytoscape. Nodes arising from the “input list” are shown as 
white squares, whereas enriched nodes are represented by red triangles. p 
< 0.01.
Figure 4: Enriched networks obtained with PPI spider. Panel A: A maximum 
of one intermediate node was allowed to be added. Panel B: A maximum of 
two intermediate nodes was allowed to be added. Network visualization was 
obtained using Cytoscape. p < 0.01. Nodes arising from the “input list” are 
shown as white/yellow squares, whereas enriched nodes are represented by 
red triangles. A highly-interconnected sub network without added nodes is 
highlighted in yellow.
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GO Category (Biological Process) XD-score q-value Overlap/Size 
blood coagulation, intrinsic pathway 1,63249 0,00000 7/17 
regulation of blood coagulation 1,18543 0,00021 3/10 
positive regulation of blood coagulation 0,78543 0,02288 2/10 
positive regulation of activated T cell 
proliferation 0,78543 0,00065 3/15 
positive regulation of glycogen 
biosynthetic process 0,71270 0,02540 2/11 
fibrinolysis 0,65210 0,00099 3/18 
protein localization at cell surface 0,55686 0,03839 2/14 
GO Category (Molecular Function) XD-score q-value Overlap/Size 
insulin-like growth factor receptor 
binding 0,65619 0,01662 2/12 
eukaryotic cell surface binding 0,51126 0,00296 3/23 
insulin-like growth factor binding 0,46011 0,02919 2/17 
insulin receptor binding 0,40332 0,00298 3/29 
Rho GTPase binding 0,33735 0,04721 2/23 
GO Category (Cellular Component) XD-score q-value Overlap/Size 
platelet alpha granule 1,33158 0,00000 4/12 
platelet alpha granule lumen 0,59768 0,00000 7/46 
Table 5: Over-Representation analysis of the network displayed in Figure 3, Panel A.
GO Category (Biological Process) XD-score q-value Overlap/Size 
blood coagulation, intrinsic pathway 1,61553 0,00000 7/17 
negative regulation of fibrinolysis 1,16847 0,00107 3/10 
regulation of blood coagulation 1,16847 0,00107 3/10 
fibrinolysis 1,07959 0,00000 5/18 
positive regulation of blood coagulation 0,76847 0,04487 2/10 
positive regulation of activated T cell 
proliferation 0,76847 0,00334 3/15 
positive regulation of insulin-like growth 
factor receptor signaling pathway 0,76847 0,04487 2/10 
platelet degranulation 0,75795 0,00000 15/76 
positive regulation of glycogen 
biosynthetic process 0,69575 0,05110 2/11 
tissue regeneration 0,67436 0,00459 3/17 
protein localization at cell surface 0,53990 0,06812 2/14 
positive regulation of collagen 
biosynthetic process 0,53990 0,06812 2/14 
myoblast differentiation 0,53990 0,06812 2/14 
leukocyte cell-cell adhesion 0,49021 0,01018 3/23 
protein polymerization 0,49021 0,01018 3/23 
GO Category (Molecular Function) XD-score q-value Overlap/Size 
insulin-like growth factor binding 0,68349 0,00260 3/17 
eukaryotic cell surface binding 0,67326 0,00040 4/23 
fibronectin binding 0,64427 0,00260 3/18 
insulin-like growth factor receptor 
binding 0,64427 0,03254 2/12 
laminin binding 0,51094 0,04795 2/15 
protease binding 0,40550 0,00040 5/47 
insulin receptor binding 0,39140 0,00902 3/29 
GO Category (Cellular Component) XD-score q-value Overlap/Size 
platelet alpha granule 1,31763 0,00001 4/12 
platelet alpha granule lumen 0,93156 0,00000 11/46 
fascia adherens 0,59042 0,03764 2/13 
cortical actin cytoskeleton 0,39609 0,07391 2/19 
podosome 0,37504 0,53453 1/10 
Table 6: Over-representation analysis of the network displayed in Figure 3, Panel B.
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as a reference (Figure 4). In the resulting networks, 18 nodes (Figure 
4, Panel A) and 26 nodes (Figure 4, Panel B) overlapped with the 
input list, respectively. Interestingly, a subnetwork of 11 interacting 
proteins was detected without any added node. References for the 
protein-protein interaction pairs defining the edges of Figure 4 are 
reported in the Supplementary Table 2. 
Over-representation analysis of the enriched networks
Enriched networks were analyzed by ORA within the specific 
network-based environment provided by the Cytoscape platform. 
As far as pathway-based networks are concerned, the analysis was 
limited to GO terms. As a first approach, the protein set of Figure 
3A was analyzed, and the results are listed in Table 5. In addition 
to GO categories intrinsically linked to blood coagulation, a BP 
term associated with T-cell involvement was significantly over-
represented, suggesting a role of lymphocyte cell-mediated responses 
in the composition of the plasma proteome AAA fingerprint. 
The same is supported by MF terms being over-represented in the 
present analysis, such as signal transduction pathways associated to 
surface binding and growth factor receptors. However, the analysis 
of this enriched network did not add a significant amount of new 
information to the analysis of the input list. Therefore, a more 
extended enrichment was taken into account. The analysis of the 
extended network (Figure 3, Panel B) revealed the identification of 
other categories possibly involved in the AAA pathogenetic process 
(Table 6). By allowing a maximum of two intermediate nodes to 
be inserted in the pathway-based network, stronger roles for cell-
cell/ECM interaction and leukocyte-mediated response became 
appreciable in the plasma proteome. The ORA procedure was also 
performed on the protein-protein interaction networks. A physical-
interaction-based enrichment procedure may potentially explore 
distinct pathways and/or GO categories that would have been 
restricted by a pathway-based procedure. Accordingly, the highly 
interconnected subnetwork highlighted in Figure 4A was analyzed as 
GO Category (Biological Process) XD-score q-value Overlap/Size 
reverse cholesterol transport 0,72179 0,01239 2/11 
protein polymerization 0,51626 0,00047 3/23 
triglyceride homeostasis 0,39452 1,00000 1/10 
endothelial cell proliferation 0,39452 1,00000 1/10 
complement activation 0,35815 0,04435 2/22 
cholesterol efflux 0,35815 1,00000 1/11 
lipid storage 0,32785 1,00000 1/12 
iron ion transport 0,32785 1,00000 1/12 
platelet degranulation 0,31031 0,00000 6/76 
GO Category (Molecular Function) XD-score q-value Overlap/Size 
eukaryotic cell surface binding 0,51797 0,00055 3/23 
lipid transporter activity 0,32956 0,91340 1/12 
GO Category (Cellular Component) XD-score q-value Overlap/Size 
platelet alpha granule 0,99286 0,00002 3/12 
platelet alpha granule lumen 0,34068 0,00001 4/46 
very-low-density lipoprotein particle 0,32619 0,43292 1/12 
Table 7: Over-Representation analysis of the subnetwork highlighted in Figure 4, Panel A.
GO Category (Biological Process) XD-score q-value Overlap/Size 
reverse cholesterol transport 0,71498 0,05011 2/11 
platelet degranulation 0,57981 0,00000 10/76 
protein localization at cell surface 0,55914 0,07227 2/14 
protein polymerization 0,50945 0,00533 3/23 
GO Category (Molecular Function) XD-score q-value Overlap/Size 
eukaryotic cell surface binding 0,51256 0,00523 3/23 
GO Category (Cellular Component) XD-score q-value Overlap/Size 
platelet alpha granule 0,98688 0,00013 3/12 
platelet alpha granule lumen 0,61731 0,00000 6/46 
Wiki Pathways XD-score q-value Overlap/Size 
Blood Clotting Cascade 0,55235 0,00472 3/21 
Reactome XD-score q-value Overlap/Size 
COMMON PATHWAY 0,89808 0,00091 3/13 
GRB2 SOS PROVIDES LINKAGE TO 
MAPK SIGNALING FOR INTEGRINS 
0,77500 0,00108 3/15 
P130CAS LINKAGE TO MAPK 
SIGNALING FOR INTEGRINS 
0,77500 0,00108 3/15 
FURTHER PLATELET RELEASATE 0,73691 0,00007 4/21 
PLATELET DEGRANULATION 0,53750 0,00000 10/80 
KEGG XD-score q-value Overlap/Size 
Complement and coagulation cascades 0,29122 0,00041 5/65 
Table 8: Over-representation analysis of the network shown in Figure 4, Panel A.
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a standalone network (Table 7), and the whole graph was later taken 
into account to find over-represented GO categories and reactome 
pathways (Table 8). The analysis of the interconnected subcluster 
highlighted in Figure 4A drew attention to lipid storage and transport 
and again an involvement for platelet degranulation. The analysis 
of the whole network indicated the potential molecular mediators 
of the cellular response evidenced above. In particular, the signal 
transduction pathways linked to integrin signaling such as the GRB2/
SOS/ERK cascade was highly prevalent. The same ORA procedure 
applied to the network reported in Figure 4B did not add any other 
significant category/pathway to the results (Supplementary Table 3). 
Concluding remarks 
A thorough systems biology analysis of the complex plasma 
protein panel associated with AAA has highlighted the relevant 
presence of proteins linked to blood coagulation and to the proteolytic 
enzyme cascade leading to blood clotting. Moreover, input list of 
proteins uncovered significant functional connections with biological 
processes and molecular functions mediated by blood cells. In 
particular, cell adhesion mechanisms mediated by integrins, signal 
transduction pathways elicited by cytokines and growth factors, 
and markers of the inflammatory response represent a valuable 
pool of candidate novel biomarkers of AAA outcomes. As reported 
by Albert-László Barabási [22] an integrated understanding of the 
interactions among the genome, the proteome, the environment and 
the pathophenome, mediated by the underlying cellular network, 
offers a basis for the cells’ global organization - the ‘think globally, act 
locally’ paradigm of network medicine.
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